Global CD137 Antibody Production, Demand and Key Producers, 2022-2028
CD137 antibody is an unconjugated antibody to CD137 (TNFRSF9 / 4-1BB).
This report studies the global CD137 Antibody demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CD137 Antibody, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD137 Antibody that contribute to its increasing demand across many markets.
The global CD137 Antibody market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global CD137 Antibody total market, 2017-2028, (USD Million)
Global CD137 Antibody total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: CD137 Antibody total market, key domestic companies and share, (USD Million)
Global CD137 Antibody revenue by player and market share 2017-2022, (USD Million)
Global CD137 Antibody total market by Type, CAGR, 2017-2028, (USD Million)
Global CD137 Antibody total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global CD137 Antibody market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sino Biological, Inc., Thermo Fisher, LifeSpan BioSciences, Inc, BioLegend, ??Abcam, Bio-Techne, GeneTex, Bio-Rad Laboratories, Inc. and Arigo Biolaboratories Corp., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CD137 Antibody market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global CD137 Antibody Market, By Region:
1. How big is the global CD137 Antibody market?
2. What is the demand of the global CD137 Antibody market?
3. What is the year over year growth of the global CD137 Antibody market?
4. What is the total value of the global CD137 Antibody market?
5. Who are the major players in the global CD137 Antibody market?
6. What are the growth factors driving the market demand?
This report studies the global CD137 Antibody demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CD137 Antibody, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD137 Antibody that contribute to its increasing demand across many markets.
The global CD137 Antibody market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global CD137 Antibody total market, 2017-2028, (USD Million)
Global CD137 Antibody total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: CD137 Antibody total market, key domestic companies and share, (USD Million)
Global CD137 Antibody revenue by player and market share 2017-2022, (USD Million)
Global CD137 Antibody total market by Type, CAGR, 2017-2028, (USD Million)
Global CD137 Antibody total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global CD137 Antibody market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sino Biological, Inc., Thermo Fisher, LifeSpan BioSciences, Inc, BioLegend, ??Abcam, Bio-Techne, GeneTex, Bio-Rad Laboratories, Inc. and Arigo Biolaboratories Corp., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CD137 Antibody market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global CD137 Antibody Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monoclonal Antibody
- Polyclonal Antibody
- Flow Cytometry
- ELISA
- Immunoprecipitation
- Other
- Sino Biological, Inc.
- Thermo Fisher
- LifeSpan BioSciences, Inc
- BioLegend
- ??Abcam
- Bio-Techne
- GeneTex
- Bio-Rad Laboratories, Inc.
- Arigo Biolaboratories Corp.
- Merck
- Cell Signaling Technology, Inc.
- MyBiosource, Inc.
- Boster Biological Technology
- Biocare Medical, LLC
- Signalway Antibody LLC
- NSJ Bioreagents
- Leinco Technologies
- Wuhan Fine Biotech Co., Ltd.
- Elabscience Biotechnology Inc.
- Biotium
- Bioss Inc
- Miltenyi Biotec
1. How big is the global CD137 Antibody market?
2. What is the demand of the global CD137 Antibody market?
3. What is the year over year growth of the global CD137 Antibody market?
4. What is the total value of the global CD137 Antibody market?
5. Who are the major players in the global CD137 Antibody market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 CD137 Antibody Introduction
1.2 World CD137 Antibody Market Size & Forecast (2017 & 2021 & 2028)
1.3 World CD137 Antibody Total Market by Region
1.3.1 World CD137 Antibody Market Size by Region (2017-2028)
1.3.2 United States CD137 Antibody Market Size (2017-2028)
1.3.3 China CD137 Antibody Market Size (2017-2028)
1.3.4 Europe CD137 Antibody Market Size (2017-2028)
1.3.5 Japan CD137 Antibody Market Size (2017-2028)
1.3.6 South Korea CD137 Antibody Market Size (2017-2028)
1.3.7 ASEAN CD137 Antibody Market Size (2017-2028)
1.3.8 India CD137 Antibody Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 CD137 Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CD137 Antibody Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD CD137 ANTIBODY COMPANIES COMPETITIVE ANALYSIS
2.1 World CD137 Antibody Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global CD137 Antibody Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for CD137 Antibody in 2021
2.2.3 Global Concentration Ratios (CR8) for CD137 Antibody in 2021
2.3 CD137 Antibody Company Evaluation Quadrant
2.4 CD137 Antibody Market: Overall Company Footprint Analysis
2.4.1 CD137 Antibody Market: Region Footprint
2.4.2 CD137 Antibody Market: Company Product Type Footprint
2.4.3 CD137 Antibody Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: CD137 Antibody Market Comparison
3.1.1 United States VS China: CD137 Antibody Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: CD137 Antibody Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States CD137 Antibody Major Players and Market Share, 2017-2022
3.2.1 Major Players of CD137 Antibody in United States, Headquarters (States, Country)
3.2.2 United States CD137 Antibody Revenue by Domestic Player, (2017-2022)
3.3 China CD137 Antibody Major Players and Market Share, 2017-2022
3.3.1 Major Players of CD137 Antibody in China, Headquarters (Province, Country)
3.3.2 China CD137 Antibody Revenue by Domestic Player, (2017-2022)
3.4 Rest of World CD137 Antibody Major Players and Market Share, 2017-2022
3.4.1 Major Players of CD137 Antibody in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World CD137 Antibody Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World CD137 Antibody Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Monoclonal Antibody
4.2.2 Polyclonal Antibody
4.3 Market Segment by Type
4.3.1 World CD137 Antibody Market Size by Type (2017-2022)
4.3.2 World CD137 Antibody Market Size by Type (2023-2028)
4.3.3 World CD137 Antibody Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World CD137 Antibody Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Flow Cytometry
5.2.2 ELISA
5.2.3 Immunoprecipitation
5.2.4 Other
5.2.5 Other
5.3 Market Segment by Application
5.3.1 World CD137 Antibody Market Size by Application (2017-2022)
5.3.2 World CD137 Antibody Market Size by Application (2023-2028)
5.3.3 World CD137 Antibody Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Sino Biological, Inc.
6.1.1 Sino Biological, Inc. Details
6.1.2 Sino Biological, Inc. Major Business
6.1.3 Sino Biological, Inc. CD137 Antibody Product and Services
6.1.4 Sino Biological, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Sino Biological, Inc. Recent Developments/Updates
6.1.6 Sino Biological, Inc. Competitive Strengths & Weaknesses
6.2 Thermo Fisher
6.2.1 Thermo Fisher Details
6.2.2 Thermo Fisher Major Business
6.2.3 Thermo Fisher CD137 Antibody Product and Services
6.2.4 Thermo Fisher CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Thermo Fisher Recent Developments/Updates
6.2.6 Thermo Fisher Competitive Strengths & Weaknesses
6.3 LifeSpan BioSciences, Inc
6.3.1 LifeSpan BioSciences, Inc Details
6.3.2 LifeSpan BioSciences, Inc Major Business
6.3.3 LifeSpan BioSciences, Inc CD137 Antibody Product and Services
6.3.4 LifeSpan BioSciences, Inc CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 LifeSpan BioSciences, Inc Recent Developments/Updates
6.3.6 LifeSpan BioSciences, Inc Competitive Strengths & Weaknesses
6.4 BioLegend
6.4.1 BioLegend Details
6.4.2 BioLegend Major Business
6.4.3 BioLegend CD137 Antibody Product and Services
6.4.4 BioLegend CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 BioLegend Recent Developments/Updates
6.4.6 BioLegend Competitive Strengths & Weaknesses
6.5 ??Abcam
6.5.1 ??Abcam Details
6.5.2 ??Abcam Major Business
6.5.3 ??Abcam CD137 Antibody Product and Services
6.5.4 ??Abcam CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 ??Abcam Recent Developments/Updates
6.5.6 ??Abcam Competitive Strengths & Weaknesses
6.6 Bio-Techne
6.6.1 Bio-Techne Details
6.6.2 Bio-Techne Major Business
6.6.3 Bio-Techne CD137 Antibody Product and Services
6.6.4 Bio-Techne CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Bio-Techne Recent Developments/Updates
6.6.6 Bio-Techne Competitive Strengths & Weaknesses
6.7 GeneTex
6.7.1 GeneTex Details
6.7.2 GeneTex Major Business
6.7.3 GeneTex CD137 Antibody Product and Services
6.7.4 GeneTex CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 GeneTex Recent Developments/Updates
6.7.6 GeneTex Competitive Strengths & Weaknesses
6.8 Bio-Rad Laboratories, Inc.
6.8.1 Bio-Rad Laboratories, Inc. Details
6.8.2 Bio-Rad Laboratories, Inc. Major Business
6.8.3 Bio-Rad Laboratories, Inc. CD137 Antibody Product and Services
6.8.4 Bio-Rad Laboratories, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
6.8.6 Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
6.9 Arigo Biolaboratories Corp.
6.9.1 Arigo Biolaboratories Corp. Details
6.9.2 Arigo Biolaboratories Corp. Major Business
6.9.3 Arigo Biolaboratories Corp. CD137 Antibody Product and Services
6.9.4 Arigo Biolaboratories Corp. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Arigo Biolaboratories Corp. Recent Developments/Updates
6.9.6 Arigo Biolaboratories Corp. Competitive Strengths & Weaknesses
6.10 Merck
6.10.1 Merck Details
6.10.2 Merck Major Business
6.10.3 Merck CD137 Antibody Product and Services
6.10.4 Merck CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Merck Recent Developments/Updates
6.10.6 Merck Competitive Strengths & Weaknesses
6.11 Cell Signaling Technology, Inc.
6.11.1 Cell Signaling Technology, Inc. Details
6.11.2 Cell Signaling Technology, Inc. Major Business
6.11.3 Cell Signaling Technology, Inc. CD137 Antibody Product and Services
6.11.4 Cell Signaling Technology, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Cell Signaling Technology, Inc. Recent Developments/Updates
6.11.6 Cell Signaling Technology, Inc. Competitive Strengths & Weaknesses
6.12 MyBiosource, Inc.
6.12.1 MyBiosource, Inc. Details
6.12.2 MyBiosource, Inc. Major Business
6.12.3 MyBiosource, Inc. CD137 Antibody Product and Services
6.12.4 MyBiosource, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 MyBiosource, Inc. Recent Developments/Updates
6.12.6 MyBiosource, Inc. Competitive Strengths & Weaknesses
6.13 Boster Biological Technology
6.13.1 Boster Biological Technology Details
6.13.2 Boster Biological Technology Major Business
6.13.3 Boster Biological Technology CD137 Antibody Product and Services
6.13.4 Boster Biological Technology CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Boster Biological Technology Recent Developments/Updates
6.13.6 Boster Biological Technology Competitive Strengths & Weaknesses
6.14 Biocare Medical, LLC
6.14.1 Biocare Medical, LLC Details
6.14.2 Biocare Medical, LLC Major Business
6.14.3 Biocare Medical, LLC CD137 Antibody Product and Services
6.14.4 Biocare Medical, LLC CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Biocare Medical, LLC Recent Developments/Updates
6.14.6 Biocare Medical, LLC Competitive Strengths & Weaknesses
6.15 Signalway Antibody LLC
6.15.1 Signalway Antibody LLC Details
6.15.2 Signalway Antibody LLC Major Business
6.15.3 Signalway Antibody LLC CD137 Antibody Product and Services
6.15.4 Signalway Antibody LLC CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Signalway Antibody LLC Recent Developments/Updates
6.15.6 Signalway Antibody LLC Competitive Strengths & Weaknesses
6.16 NSJ Bioreagents
6.16.1 NSJ Bioreagents Details
6.16.2 NSJ Bioreagents Major Business
6.16.3 NSJ Bioreagents CD137 Antibody Product and Services
6.16.4 NSJ Bioreagents CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 NSJ Bioreagents Recent Developments/Updates
6.16.6 NSJ Bioreagents Competitive Strengths & Weaknesses
6.17 Leinco Technologies
6.17.1 Leinco Technologies Details
6.17.2 Leinco Technologies Major Business
6.17.3 Leinco Technologies CD137 Antibody Product and Services
6.17.4 Leinco Technologies CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Leinco Technologies Recent Developments/Updates
6.17.6 Leinco Technologies Competitive Strengths & Weaknesses
6.18 Wuhan Fine Biotech Co., Ltd.
6.18.1 Wuhan Fine Biotech Co., Ltd. Details
6.18.2 Wuhan Fine Biotech Co., Ltd. Major Business
6.18.3 Wuhan Fine Biotech Co., Ltd. CD137 Antibody Product and Services
6.18.4 Wuhan Fine Biotech Co., Ltd. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
6.18.6 Wuhan Fine Biotech Co., Ltd. Competitive Strengths & Weaknesses
6.19 Elabscience Biotechnology Inc.
6.19.1 Elabscience Biotechnology Inc. Details
6.19.2 Elabscience Biotechnology Inc. Major Business
6.19.3 Elabscience Biotechnology Inc. CD137 Antibody Product and Services
6.19.4 Elabscience Biotechnology Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Elabscience Biotechnology Inc. Recent Developments/Updates
6.19.6 Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
6.20 Biotium
6.20.1 Biotium Details
6.20.2 Biotium Major Business
6.20.3 Biotium CD137 Antibody Product and Services
6.20.4 Biotium CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 Biotium Recent Developments/Updates
6.20.6 Biotium Competitive Strengths & Weaknesses
6.21 Bioss Inc
6.21.1 Bioss Inc Details
6.21.2 Bioss Inc Major Business
6.21.3 Bioss Inc CD137 Antibody Product and Services
6.21.4 Bioss Inc CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.21.5 Bioss Inc Recent Developments/Updates
6.21.6 Bioss Inc Competitive Strengths & Weaknesses
6.22 Miltenyi Biotec
6.22.1 Miltenyi Biotec Details
6.22.2 Miltenyi Biotec Major Business
6.22.3 Miltenyi Biotec CD137 Antibody Product and Services
6.22.4 Miltenyi Biotec CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.22.5 Miltenyi Biotec Recent Developments/Updates
6.22.6 Miltenyi Biotec Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of CD137 Antibody and Key Manufacturers
7.2 CD137 Antibody Manufacturing Costs
7.3 CD137 Antibody Production Process
7.4 CD137 Antibody Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for CD137 Antibody Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 CD137 Antibody Typical Distributors
8.3 CD137 Antibody Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 CD137 Antibody Introduction
1.2 World CD137 Antibody Market Size & Forecast (2017 & 2021 & 2028)
1.3 World CD137 Antibody Total Market by Region
1.3.1 World CD137 Antibody Market Size by Region (2017-2028)
1.3.2 United States CD137 Antibody Market Size (2017-2028)
1.3.3 China CD137 Antibody Market Size (2017-2028)
1.3.4 Europe CD137 Antibody Market Size (2017-2028)
1.3.5 Japan CD137 Antibody Market Size (2017-2028)
1.3.6 South Korea CD137 Antibody Market Size (2017-2028)
1.3.7 ASEAN CD137 Antibody Market Size (2017-2028)
1.3.8 India CD137 Antibody Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 CD137 Antibody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CD137 Antibody Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD CD137 ANTIBODY COMPANIES COMPETITIVE ANALYSIS
2.1 World CD137 Antibody Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global CD137 Antibody Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for CD137 Antibody in 2021
2.2.3 Global Concentration Ratios (CR8) for CD137 Antibody in 2021
2.3 CD137 Antibody Company Evaluation Quadrant
2.4 CD137 Antibody Market: Overall Company Footprint Analysis
2.4.1 CD137 Antibody Market: Region Footprint
2.4.2 CD137 Antibody Market: Company Product Type Footprint
2.4.3 CD137 Antibody Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: CD137 Antibody Market Comparison
3.1.1 United States VS China: CD137 Antibody Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: CD137 Antibody Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States CD137 Antibody Major Players and Market Share, 2017-2022
3.2.1 Major Players of CD137 Antibody in United States, Headquarters (States, Country)
3.2.2 United States CD137 Antibody Revenue by Domestic Player, (2017-2022)
3.3 China CD137 Antibody Major Players and Market Share, 2017-2022
3.3.1 Major Players of CD137 Antibody in China, Headquarters (Province, Country)
3.3.2 China CD137 Antibody Revenue by Domestic Player, (2017-2022)
3.4 Rest of World CD137 Antibody Major Players and Market Share, 2017-2022
3.4.1 Major Players of CD137 Antibody in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World CD137 Antibody Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World CD137 Antibody Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Monoclonal Antibody
4.2.2 Polyclonal Antibody
4.3 Market Segment by Type
4.3.1 World CD137 Antibody Market Size by Type (2017-2022)
4.3.2 World CD137 Antibody Market Size by Type (2023-2028)
4.3.3 World CD137 Antibody Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World CD137 Antibody Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Flow Cytometry
5.2.2 ELISA
5.2.3 Immunoprecipitation
5.2.4 Other
5.2.5 Other
5.3 Market Segment by Application
5.3.1 World CD137 Antibody Market Size by Application (2017-2022)
5.3.2 World CD137 Antibody Market Size by Application (2023-2028)
5.3.3 World CD137 Antibody Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Sino Biological, Inc.
6.1.1 Sino Biological, Inc. Details
6.1.2 Sino Biological, Inc. Major Business
6.1.3 Sino Biological, Inc. CD137 Antibody Product and Services
6.1.4 Sino Biological, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Sino Biological, Inc. Recent Developments/Updates
6.1.6 Sino Biological, Inc. Competitive Strengths & Weaknesses
6.2 Thermo Fisher
6.2.1 Thermo Fisher Details
6.2.2 Thermo Fisher Major Business
6.2.3 Thermo Fisher CD137 Antibody Product and Services
6.2.4 Thermo Fisher CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Thermo Fisher Recent Developments/Updates
6.2.6 Thermo Fisher Competitive Strengths & Weaknesses
6.3 LifeSpan BioSciences, Inc
6.3.1 LifeSpan BioSciences, Inc Details
6.3.2 LifeSpan BioSciences, Inc Major Business
6.3.3 LifeSpan BioSciences, Inc CD137 Antibody Product and Services
6.3.4 LifeSpan BioSciences, Inc CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 LifeSpan BioSciences, Inc Recent Developments/Updates
6.3.6 LifeSpan BioSciences, Inc Competitive Strengths & Weaknesses
6.4 BioLegend
6.4.1 BioLegend Details
6.4.2 BioLegend Major Business
6.4.3 BioLegend CD137 Antibody Product and Services
6.4.4 BioLegend CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 BioLegend Recent Developments/Updates
6.4.6 BioLegend Competitive Strengths & Weaknesses
6.5 ??Abcam
6.5.1 ??Abcam Details
6.5.2 ??Abcam Major Business
6.5.3 ??Abcam CD137 Antibody Product and Services
6.5.4 ??Abcam CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 ??Abcam Recent Developments/Updates
6.5.6 ??Abcam Competitive Strengths & Weaknesses
6.6 Bio-Techne
6.6.1 Bio-Techne Details
6.6.2 Bio-Techne Major Business
6.6.3 Bio-Techne CD137 Antibody Product and Services
6.6.4 Bio-Techne CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Bio-Techne Recent Developments/Updates
6.6.6 Bio-Techne Competitive Strengths & Weaknesses
6.7 GeneTex
6.7.1 GeneTex Details
6.7.2 GeneTex Major Business
6.7.3 GeneTex CD137 Antibody Product and Services
6.7.4 GeneTex CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 GeneTex Recent Developments/Updates
6.7.6 GeneTex Competitive Strengths & Weaknesses
6.8 Bio-Rad Laboratories, Inc.
6.8.1 Bio-Rad Laboratories, Inc. Details
6.8.2 Bio-Rad Laboratories, Inc. Major Business
6.8.3 Bio-Rad Laboratories, Inc. CD137 Antibody Product and Services
6.8.4 Bio-Rad Laboratories, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
6.8.6 Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
6.9 Arigo Biolaboratories Corp.
6.9.1 Arigo Biolaboratories Corp. Details
6.9.2 Arigo Biolaboratories Corp. Major Business
6.9.3 Arigo Biolaboratories Corp. CD137 Antibody Product and Services
6.9.4 Arigo Biolaboratories Corp. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Arigo Biolaboratories Corp. Recent Developments/Updates
6.9.6 Arigo Biolaboratories Corp. Competitive Strengths & Weaknesses
6.10 Merck
6.10.1 Merck Details
6.10.2 Merck Major Business
6.10.3 Merck CD137 Antibody Product and Services
6.10.4 Merck CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Merck Recent Developments/Updates
6.10.6 Merck Competitive Strengths & Weaknesses
6.11 Cell Signaling Technology, Inc.
6.11.1 Cell Signaling Technology, Inc. Details
6.11.2 Cell Signaling Technology, Inc. Major Business
6.11.3 Cell Signaling Technology, Inc. CD137 Antibody Product and Services
6.11.4 Cell Signaling Technology, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Cell Signaling Technology, Inc. Recent Developments/Updates
6.11.6 Cell Signaling Technology, Inc. Competitive Strengths & Weaknesses
6.12 MyBiosource, Inc.
6.12.1 MyBiosource, Inc. Details
6.12.2 MyBiosource, Inc. Major Business
6.12.3 MyBiosource, Inc. CD137 Antibody Product and Services
6.12.4 MyBiosource, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 MyBiosource, Inc. Recent Developments/Updates
6.12.6 MyBiosource, Inc. Competitive Strengths & Weaknesses
6.13 Boster Biological Technology
6.13.1 Boster Biological Technology Details
6.13.2 Boster Biological Technology Major Business
6.13.3 Boster Biological Technology CD137 Antibody Product and Services
6.13.4 Boster Biological Technology CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Boster Biological Technology Recent Developments/Updates
6.13.6 Boster Biological Technology Competitive Strengths & Weaknesses
6.14 Biocare Medical, LLC
6.14.1 Biocare Medical, LLC Details
6.14.2 Biocare Medical, LLC Major Business
6.14.3 Biocare Medical, LLC CD137 Antibody Product and Services
6.14.4 Biocare Medical, LLC CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Biocare Medical, LLC Recent Developments/Updates
6.14.6 Biocare Medical, LLC Competitive Strengths & Weaknesses
6.15 Signalway Antibody LLC
6.15.1 Signalway Antibody LLC Details
6.15.2 Signalway Antibody LLC Major Business
6.15.3 Signalway Antibody LLC CD137 Antibody Product and Services
6.15.4 Signalway Antibody LLC CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Signalway Antibody LLC Recent Developments/Updates
6.15.6 Signalway Antibody LLC Competitive Strengths & Weaknesses
6.16 NSJ Bioreagents
6.16.1 NSJ Bioreagents Details
6.16.2 NSJ Bioreagents Major Business
6.16.3 NSJ Bioreagents CD137 Antibody Product and Services
6.16.4 NSJ Bioreagents CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 NSJ Bioreagents Recent Developments/Updates
6.16.6 NSJ Bioreagents Competitive Strengths & Weaknesses
6.17 Leinco Technologies
6.17.1 Leinco Technologies Details
6.17.2 Leinco Technologies Major Business
6.17.3 Leinco Technologies CD137 Antibody Product and Services
6.17.4 Leinco Technologies CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Leinco Technologies Recent Developments/Updates
6.17.6 Leinco Technologies Competitive Strengths & Weaknesses
6.18 Wuhan Fine Biotech Co., Ltd.
6.18.1 Wuhan Fine Biotech Co., Ltd. Details
6.18.2 Wuhan Fine Biotech Co., Ltd. Major Business
6.18.3 Wuhan Fine Biotech Co., Ltd. CD137 Antibody Product and Services
6.18.4 Wuhan Fine Biotech Co., Ltd. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
6.18.6 Wuhan Fine Biotech Co., Ltd. Competitive Strengths & Weaknesses
6.19 Elabscience Biotechnology Inc.
6.19.1 Elabscience Biotechnology Inc. Details
6.19.2 Elabscience Biotechnology Inc. Major Business
6.19.3 Elabscience Biotechnology Inc. CD137 Antibody Product and Services
6.19.4 Elabscience Biotechnology Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Elabscience Biotechnology Inc. Recent Developments/Updates
6.19.6 Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
6.20 Biotium
6.20.1 Biotium Details
6.20.2 Biotium Major Business
6.20.3 Biotium CD137 Antibody Product and Services
6.20.4 Biotium CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 Biotium Recent Developments/Updates
6.20.6 Biotium Competitive Strengths & Weaknesses
6.21 Bioss Inc
6.21.1 Bioss Inc Details
6.21.2 Bioss Inc Major Business
6.21.3 Bioss Inc CD137 Antibody Product and Services
6.21.4 Bioss Inc CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.21.5 Bioss Inc Recent Developments/Updates
6.21.6 Bioss Inc Competitive Strengths & Weaknesses
6.22 Miltenyi Biotec
6.22.1 Miltenyi Biotec Details
6.22.2 Miltenyi Biotec Major Business
6.22.3 Miltenyi Biotec CD137 Antibody Product and Services
6.22.4 Miltenyi Biotec CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022)
6.22.5 Miltenyi Biotec Recent Developments/Updates
6.22.6 Miltenyi Biotec Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of CD137 Antibody and Key Manufacturers
7.2 CD137 Antibody Manufacturing Costs
7.3 CD137 Antibody Production Process
7.4 CD137 Antibody Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for CD137 Antibody Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 CD137 Antibody Typical Distributors
8.3 CD137 Antibody Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World CD137 Antibody Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World CD137 Antibody Market Size by Region (2017-2022) & (USD Million)
Table 3. World CD137 Antibody Market Size by Region (2023-2028) & (USD Million)
Table 4. World CD137 Antibody Market Size Market Share by Region (2017-2022)
Table 5. World CD137 Antibody Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World CD137 Antibody Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key CD137 Antibody Players in 2021
Table 9. World CD137 Antibody Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global CD137 Antibody Company Evaluation Quadrant
Table 11. Head Office of Key CD137 Antibody Player
Table 12. CD137 Antibody Market: Company Product Type Footprint
Table 13. CD137 Antibody Market: Company Product Application Footprint
Table 14. CD137 Antibody Mergers & Acquisitions Activity
Table 15. United States VS China CD137 Antibody Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of CD137 Antibody in United States, Headquarters (States, Country)
Table 17. United States CD137 Antibody Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States CD137 Antibody Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of CD137 Antibody in China, Company Headquarters (Province, Country)
Table 20. China CD137 Antibody Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China CD137 Antibody Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of CD137 Antibody in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World CD137 Antibody Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World CD137 Antibody Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World CD137 Antibody Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World CD137 Antibody Revenue by Type (2017-2022) & (USD Million)
Table 27. World CD137 Antibody Revenue by Type (2023-2028) & (USD Million)
Table 28. World CD137 Antibody Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World CD137 Antibody Revenue by Application (2017-2022) & (USD Million)
Table 30. World CD137 Antibody Revenue by Application (2023-2028) & (USD Million)
Table 31. Sino Biological, Inc. Basic Information, Area Served and Competitors
Table 32. Sino Biological, Inc. Major Business
Table 33. Sino Biological, Inc. CD137 Antibody Product and Services
Table 34. Sino Biological, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Sino Biological, Inc. Recent Developments/Updates
Table 36. Sino Biological, Inc. Competitive Strengths & Weaknesses
Table 37. Thermo Fisher Basic Information, Area Served and Competitors
Table 38. Thermo Fisher Major Business
Table 39. Thermo Fisher CD137 Antibody Product and Services
Table 40. Thermo Fisher CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Thermo Fisher Recent Developments/Updates
Table 42. Thermo Fisher Competitive Strengths & Weaknesses
Table 43. LifeSpan BioSciences, Inc Basic Information, Area Served and Competitors
Table 44. LifeSpan BioSciences, Inc Major Business
Table 45. LifeSpan BioSciences, Inc CD137 Antibody Product and Services
Table 46. LifeSpan BioSciences, Inc CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. LifeSpan BioSciences, Inc Recent Developments/Updates
Table 48. LifeSpan BioSciences, Inc Competitive Strengths & Weaknesses
Table 49. BioLegend Basic Information, Area Served and Competitors
Table 50. BioLegend Major Business
Table 51. BioLegend CD137 Antibody Product and Services
Table 52. BioLegend CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. BioLegend Recent Developments/Updates
Table 54. BioLegend Competitive Strengths & Weaknesses
Table 55. ??Abcam Basic Information, Area Served and Competitors
Table 56. ??Abcam Major Business
Table 57. ??Abcam CD137 Antibody Product and Services
Table 58. ??Abcam CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. ??Abcam Recent Developments/Updates
Table 60. ??Abcam Competitive Strengths & Weaknesses
Table 61. Bio-Techne Basic Information, Area Served and Competitors
Table 62. Bio-Techne Major Business
Table 63. Bio-Techne CD137 Antibody Product and Services
Table 64. Bio-Techne CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Bio-Techne Recent Developments/Updates
Table 66. Bio-Techne Competitive Strengths & Weaknesses
Table 67. GeneTex Basic Information, Area Served and Competitors
Table 68. GeneTex Major Business
Table 69. GeneTex CD137 Antibody Product and Services
Table 70. GeneTex CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. GeneTex Recent Developments/Updates
Table 72. GeneTex Competitive Strengths & Weaknesses
Table 73. Bio-Rad Laboratories, Inc. Basic Information, Area Served and Competitors
Table 74. Bio-Rad Laboratories, Inc. Major Business
Table 75. Bio-Rad Laboratories, Inc. CD137 Antibody Product and Services
Table 76. Bio-Rad Laboratories, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 78. Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
Table 79. Arigo Biolaboratories Corp. Basic Information, Area Served and Competitors
Table 80. Arigo Biolaboratories Corp. Major Business
Table 81. Arigo Biolaboratories Corp. CD137 Antibody Product and Services
Table 82. Arigo Biolaboratories Corp. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Arigo Biolaboratories Corp. Recent Developments/Updates
Table 84. Arigo Biolaboratories Corp. Competitive Strengths & Weaknesses
Table 85. Merck Basic Information, Area Served and Competitors
Table 86. Merck Major Business
Table 87. Merck CD137 Antibody Product and Services
Table 88. Merck CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Merck Recent Developments/Updates
Table 90. Merck Competitive Strengths & Weaknesses
Table 91. Cell Signaling Technology, Inc. Basic Information, Area Served and Competitors
Table 92. Cell Signaling Technology, Inc. Major Business
Table 93. Cell Signaling Technology, Inc. CD137 Antibody Product and Services
Table 94. Cell Signaling Technology, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Cell Signaling Technology, Inc. Recent Developments/Updates
Table 96. Cell Signaling Technology, Inc. Competitive Strengths & Weaknesses
Table 97. MyBiosource, Inc. Basic Information, Area Served and Competitors
Table 98. MyBiosource, Inc. Major Business
Table 99. MyBiosource, Inc. CD137 Antibody Product and Services
Table 100. MyBiosource, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. MyBiosource, Inc. Recent Developments/Updates
Table 102. MyBiosource, Inc. Competitive Strengths & Weaknesses
Table 103. Boster Biological Technology Basic Information, Area Served and Competitors
Table 104. Boster Biological Technology Major Business
Table 105. Boster Biological Technology CD137 Antibody Product and Services
Table 106. Boster Biological Technology CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Boster Biological Technology Recent Developments/Updates
Table 108. Boster Biological Technology Competitive Strengths & Weaknesses
Table 109. Biocare Medical, LLC Basic Information, Area Served and Competitors
Table 110. Biocare Medical, LLC Major Business
Table 111. Biocare Medical, LLC CD137 Antibody Product and Services
Table 112. Biocare Medical, LLC CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Biocare Medical, LLC Recent Developments/Updates
Table 114. Biocare Medical, LLC Competitive Strengths & Weaknesses
Table 115. Signalway Antibody LLC Basic Information, Area Served and Competitors
Table 116. Signalway Antibody LLC Major Business
Table 117. Signalway Antibody LLC CD137 Antibody Product and Services
Table 118. Signalway Antibody LLC CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Signalway Antibody LLC Recent Developments/Updates
Table 120. Signalway Antibody LLC Competitive Strengths & Weaknesses
Table 121. NSJ Bioreagents Basic Information, Area Served and Competitors
Table 122. NSJ Bioreagents Major Business
Table 123. NSJ Bioreagents CD137 Antibody Product and Services
Table 124. NSJ Bioreagents CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. NSJ Bioreagents Recent Developments/Updates
Table 126. NSJ Bioreagents Competitive Strengths & Weaknesses
Table 127. Leinco Technologies Basic Information, Area Served and Competitors
Table 128. Leinco Technologies Major Business
Table 129. Leinco Technologies CD137 Antibody Product and Services
Table 130. Leinco Technologies CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Leinco Technologies Recent Developments/Updates
Table 132. Leinco Technologies Competitive Strengths & Weaknesses
Table 133. Wuhan Fine Biotech Co., Ltd. Basic Information, Area Served and Competitors
Table 134. Wuhan Fine Biotech Co., Ltd. Major Business
Table 135. Wuhan Fine Biotech Co., Ltd. CD137 Antibody Product and Services
Table 136. Wuhan Fine Biotech Co., Ltd. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
Table 138. Wuhan Fine Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 139. Elabscience Biotechnology Inc. Basic Information, Area Served and Competitors
Table 140. Elabscience Biotechnology Inc. Major Business
Table 141. Elabscience Biotechnology Inc. CD137 Antibody Product and Services
Table 142. Elabscience Biotechnology Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Elabscience Biotechnology Inc. Recent Developments/Updates
Table 144. Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
Table 145. Biotium Basic Information, Area Served and Competitors
Table 146. Biotium Major Business
Table 147. Biotium CD137 Antibody Product and Services
Table 148. Biotium CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 149. Biotium Recent Developments/Updates
Table 150. Biotium Competitive Strengths & Weaknesses
Table 151. Bioss Inc Basic Information, Area Served and Competitors
Table 152. Bioss Inc Major Business
Table 153. Bioss Inc CD137 Antibody Product and Services
Table 154. Bioss Inc CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 155. Bioss Inc Recent Developments/Updates
Table 156. Miltenyi Biotec Basic Information, Area Served and Competitors
Table 157. Miltenyi Biotec Major Business
Table 158. Miltenyi Biotec CD137 Antibody Product and Services
Table 159. Miltenyi Biotec CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 160. CD137 Antibody Raw Material
Table 161. Key Manufacturers of CD137 Antibody Raw Materials
Table 162. CD137 Antibody Typical Distributors
Table 163. CD137 Antibody Typical Customers
Table 1. World CD137 Antibody Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World CD137 Antibody Market Size by Region (2017-2022) & (USD Million)
Table 3. World CD137 Antibody Market Size by Region (2023-2028) & (USD Million)
Table 4. World CD137 Antibody Market Size Market Share by Region (2017-2022)
Table 5. World CD137 Antibody Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World CD137 Antibody Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key CD137 Antibody Players in 2021
Table 9. World CD137 Antibody Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global CD137 Antibody Company Evaluation Quadrant
Table 11. Head Office of Key CD137 Antibody Player
Table 12. CD137 Antibody Market: Company Product Type Footprint
Table 13. CD137 Antibody Market: Company Product Application Footprint
Table 14. CD137 Antibody Mergers & Acquisitions Activity
Table 15. United States VS China CD137 Antibody Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of CD137 Antibody in United States, Headquarters (States, Country)
Table 17. United States CD137 Antibody Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States CD137 Antibody Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of CD137 Antibody in China, Company Headquarters (Province, Country)
Table 20. China CD137 Antibody Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China CD137 Antibody Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of CD137 Antibody in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World CD137 Antibody Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World CD137 Antibody Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World CD137 Antibody Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World CD137 Antibody Revenue by Type (2017-2022) & (USD Million)
Table 27. World CD137 Antibody Revenue by Type (2023-2028) & (USD Million)
Table 28. World CD137 Antibody Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World CD137 Antibody Revenue by Application (2017-2022) & (USD Million)
Table 30. World CD137 Antibody Revenue by Application (2023-2028) & (USD Million)
Table 31. Sino Biological, Inc. Basic Information, Area Served and Competitors
Table 32. Sino Biological, Inc. Major Business
Table 33. Sino Biological, Inc. CD137 Antibody Product and Services
Table 34. Sino Biological, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Sino Biological, Inc. Recent Developments/Updates
Table 36. Sino Biological, Inc. Competitive Strengths & Weaknesses
Table 37. Thermo Fisher Basic Information, Area Served and Competitors
Table 38. Thermo Fisher Major Business
Table 39. Thermo Fisher CD137 Antibody Product and Services
Table 40. Thermo Fisher CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Thermo Fisher Recent Developments/Updates
Table 42. Thermo Fisher Competitive Strengths & Weaknesses
Table 43. LifeSpan BioSciences, Inc Basic Information, Area Served and Competitors
Table 44. LifeSpan BioSciences, Inc Major Business
Table 45. LifeSpan BioSciences, Inc CD137 Antibody Product and Services
Table 46. LifeSpan BioSciences, Inc CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. LifeSpan BioSciences, Inc Recent Developments/Updates
Table 48. LifeSpan BioSciences, Inc Competitive Strengths & Weaknesses
Table 49. BioLegend Basic Information, Area Served and Competitors
Table 50. BioLegend Major Business
Table 51. BioLegend CD137 Antibody Product and Services
Table 52. BioLegend CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. BioLegend Recent Developments/Updates
Table 54. BioLegend Competitive Strengths & Weaknesses
Table 55. ??Abcam Basic Information, Area Served and Competitors
Table 56. ??Abcam Major Business
Table 57. ??Abcam CD137 Antibody Product and Services
Table 58. ??Abcam CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. ??Abcam Recent Developments/Updates
Table 60. ??Abcam Competitive Strengths & Weaknesses
Table 61. Bio-Techne Basic Information, Area Served and Competitors
Table 62. Bio-Techne Major Business
Table 63. Bio-Techne CD137 Antibody Product and Services
Table 64. Bio-Techne CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Bio-Techne Recent Developments/Updates
Table 66. Bio-Techne Competitive Strengths & Weaknesses
Table 67. GeneTex Basic Information, Area Served and Competitors
Table 68. GeneTex Major Business
Table 69. GeneTex CD137 Antibody Product and Services
Table 70. GeneTex CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. GeneTex Recent Developments/Updates
Table 72. GeneTex Competitive Strengths & Weaknesses
Table 73. Bio-Rad Laboratories, Inc. Basic Information, Area Served and Competitors
Table 74. Bio-Rad Laboratories, Inc. Major Business
Table 75. Bio-Rad Laboratories, Inc. CD137 Antibody Product and Services
Table 76. Bio-Rad Laboratories, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 78. Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
Table 79. Arigo Biolaboratories Corp. Basic Information, Area Served and Competitors
Table 80. Arigo Biolaboratories Corp. Major Business
Table 81. Arigo Biolaboratories Corp. CD137 Antibody Product and Services
Table 82. Arigo Biolaboratories Corp. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Arigo Biolaboratories Corp. Recent Developments/Updates
Table 84. Arigo Biolaboratories Corp. Competitive Strengths & Weaknesses
Table 85. Merck Basic Information, Area Served and Competitors
Table 86. Merck Major Business
Table 87. Merck CD137 Antibody Product and Services
Table 88. Merck CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Merck Recent Developments/Updates
Table 90. Merck Competitive Strengths & Weaknesses
Table 91. Cell Signaling Technology, Inc. Basic Information, Area Served and Competitors
Table 92. Cell Signaling Technology, Inc. Major Business
Table 93. Cell Signaling Technology, Inc. CD137 Antibody Product and Services
Table 94. Cell Signaling Technology, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Cell Signaling Technology, Inc. Recent Developments/Updates
Table 96. Cell Signaling Technology, Inc. Competitive Strengths & Weaknesses
Table 97. MyBiosource, Inc. Basic Information, Area Served and Competitors
Table 98. MyBiosource, Inc. Major Business
Table 99. MyBiosource, Inc. CD137 Antibody Product and Services
Table 100. MyBiosource, Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. MyBiosource, Inc. Recent Developments/Updates
Table 102. MyBiosource, Inc. Competitive Strengths & Weaknesses
Table 103. Boster Biological Technology Basic Information, Area Served and Competitors
Table 104. Boster Biological Technology Major Business
Table 105. Boster Biological Technology CD137 Antibody Product and Services
Table 106. Boster Biological Technology CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Boster Biological Technology Recent Developments/Updates
Table 108. Boster Biological Technology Competitive Strengths & Weaknesses
Table 109. Biocare Medical, LLC Basic Information, Area Served and Competitors
Table 110. Biocare Medical, LLC Major Business
Table 111. Biocare Medical, LLC CD137 Antibody Product and Services
Table 112. Biocare Medical, LLC CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Biocare Medical, LLC Recent Developments/Updates
Table 114. Biocare Medical, LLC Competitive Strengths & Weaknesses
Table 115. Signalway Antibody LLC Basic Information, Area Served and Competitors
Table 116. Signalway Antibody LLC Major Business
Table 117. Signalway Antibody LLC CD137 Antibody Product and Services
Table 118. Signalway Antibody LLC CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Signalway Antibody LLC Recent Developments/Updates
Table 120. Signalway Antibody LLC Competitive Strengths & Weaknesses
Table 121. NSJ Bioreagents Basic Information, Area Served and Competitors
Table 122. NSJ Bioreagents Major Business
Table 123. NSJ Bioreagents CD137 Antibody Product and Services
Table 124. NSJ Bioreagents CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. NSJ Bioreagents Recent Developments/Updates
Table 126. NSJ Bioreagents Competitive Strengths & Weaknesses
Table 127. Leinco Technologies Basic Information, Area Served and Competitors
Table 128. Leinco Technologies Major Business
Table 129. Leinco Technologies CD137 Antibody Product and Services
Table 130. Leinco Technologies CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Leinco Technologies Recent Developments/Updates
Table 132. Leinco Technologies Competitive Strengths & Weaknesses
Table 133. Wuhan Fine Biotech Co., Ltd. Basic Information, Area Served and Competitors
Table 134. Wuhan Fine Biotech Co., Ltd. Major Business
Table 135. Wuhan Fine Biotech Co., Ltd. CD137 Antibody Product and Services
Table 136. Wuhan Fine Biotech Co., Ltd. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
Table 138. Wuhan Fine Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 139. Elabscience Biotechnology Inc. Basic Information, Area Served and Competitors
Table 140. Elabscience Biotechnology Inc. Major Business
Table 141. Elabscience Biotechnology Inc. CD137 Antibody Product and Services
Table 142. Elabscience Biotechnology Inc. CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Elabscience Biotechnology Inc. Recent Developments/Updates
Table 144. Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
Table 145. Biotium Basic Information, Area Served and Competitors
Table 146. Biotium Major Business
Table 147. Biotium CD137 Antibody Product and Services
Table 148. Biotium CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 149. Biotium Recent Developments/Updates
Table 150. Biotium Competitive Strengths & Weaknesses
Table 151. Bioss Inc Basic Information, Area Served and Competitors
Table 152. Bioss Inc Major Business
Table 153. Bioss Inc CD137 Antibody Product and Services
Table 154. Bioss Inc CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 155. Bioss Inc Recent Developments/Updates
Table 156. Miltenyi Biotec Basic Information, Area Served and Competitors
Table 157. Miltenyi Biotec Major Business
Table 158. Miltenyi Biotec CD137 Antibody Product and Services
Table 159. Miltenyi Biotec CD137 Antibody Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 160. CD137 Antibody Raw Material
Table 161. Key Manufacturers of CD137 Antibody Raw Materials
Table 162. CD137 Antibody Typical Distributors
Table 163. CD137 Antibody Typical Customers
LIST OF FIGURES
Figure 1. CD137 Antibody Picture
Figure 2. World CD137 Antibody Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World CD137 Antibody Total Market Size (2017-2028) & (USD Million)
Figure 4. World CD137 Antibody Market Size Market Share by Region (2017-2028)
Figure 5. United States CD137 Antibody Market Size (2017-2028) & (USD Million)
Figure 6. China CD137 Antibody Market Size (2017-2028) & (USD Million)
Figure 7. Europe CD137 Antibody Market Size (2017-2028) & (USD Million)
Figure 8. Japan CD137 Antibody Market Size (2017-2028) & (USD Million)
Figure 9. South Korea CD137 Antibody Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN CD137 Antibody Market Size (2017-2028) & (USD Million)
Figure 11. India CD137 Antibody Market Size (2017-2028) & (USD Million)
Figure 12. CD137 Antibody Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of CD137 Antibody by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for CD137 Antibody Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for CD137 Antibody Markets in 2021
Figure 17. United States VS China: CD137 Antibody Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World CD137 Antibody Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World CD137 Antibody Market Size Market Share by Type in 2021
Figure 20. Monoclonal Antibody
Figure 21. Polyclonal Antibody
Figure 22. World CD137 Antibody Market Size Market Share by Type (2017-2028)
Figure 23. World CD137 Antibody Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 24. World CD137 Antibody Market Size Market Share by Application in 2021
Figure 25. Flow Cytometry
Figure 26. ELISA
Figure 27. Immunoprecipitation
Figure 28. Other
Figure 29. World CD137 Antibody Market Size Market Share by Application (2017-2028)
Figure 30. Manufacturing Cost Structure Analysis of CD137 Antibody in 2021
Figure 31. Manufacturing Process Analysis of CD137 Antibody
Figure 32. CD137 Antibody Industrial Chain
Figure 33. Distribution Channel Breakdown for CD137 Antibody Shipments (%): 2017-2028
Figure 34. Direct Channel Pros & Cons
Figure 35. Indirect Channel Pros & Cons
Figure 36. Methodology
Figure 37. Research Process and Data Source
Figure 1. CD137 Antibody Picture
Figure 2. World CD137 Antibody Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World CD137 Antibody Total Market Size (2017-2028) & (USD Million)
Figure 4. World CD137 Antibody Market Size Market Share by Region (2017-2028)
Figure 5. United States CD137 Antibody Market Size (2017-2028) & (USD Million)
Figure 6. China CD137 Antibody Market Size (2017-2028) & (USD Million)
Figure 7. Europe CD137 Antibody Market Size (2017-2028) & (USD Million)
Figure 8. Japan CD137 Antibody Market Size (2017-2028) & (USD Million)
Figure 9. South Korea CD137 Antibody Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN CD137 Antibody Market Size (2017-2028) & (USD Million)
Figure 11. India CD137 Antibody Market Size (2017-2028) & (USD Million)
Figure 12. CD137 Antibody Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of CD137 Antibody by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for CD137 Antibody Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for CD137 Antibody Markets in 2021
Figure 17. United States VS China: CD137 Antibody Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World CD137 Antibody Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World CD137 Antibody Market Size Market Share by Type in 2021
Figure 20. Monoclonal Antibody
Figure 21. Polyclonal Antibody
Figure 22. World CD137 Antibody Market Size Market Share by Type (2017-2028)
Figure 23. World CD137 Antibody Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 24. World CD137 Antibody Market Size Market Share by Application in 2021
Figure 25. Flow Cytometry
Figure 26. ELISA
Figure 27. Immunoprecipitation
Figure 28. Other
Figure 29. World CD137 Antibody Market Size Market Share by Application (2017-2028)
Figure 30. Manufacturing Cost Structure Analysis of CD137 Antibody in 2021
Figure 31. Manufacturing Process Analysis of CD137 Antibody
Figure 32. CD137 Antibody Industrial Chain
Figure 33. Distribution Channel Breakdown for CD137 Antibody Shipments (%): 2017-2028
Figure 34. Direct Channel Pros & Cons
Figure 35. Indirect Channel Pros & Cons
Figure 36. Methodology
Figure 37. Research Process and Data Source
